We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research | AQSE:EDEN.GB | Aquis Stock Exchange | Ordinary Share | GB0001646941 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.85 | 3.60 | 4.10 | 4.09 | 3.85 | 3.85 | 346,909 | 16:29:54 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMEDEN
RNS Number : 0270L
Eden Research plc
31 August 2023
31 August 2023
Eden Research plc
("Eden" or "the Company")
Grant of Awards under Long-Term Incentive Plan
Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in global crop protection, animal health and consumer products industries, confirms the grant of options under the Company's Long Term Incentive Plan ("LTIP") to Sean Smith, Chief Executive Officer, and Alex Abrey, Chief Finance Officer (together the "Executives"), as follows:
The Company has made a grant to the Executives, in respect of 2022 in order to ensure continuity of long term incentive, of options over 8,698,909 new Ordinary Shares in Eden ("the Options"), at a strike price of 5.05p each, being the 2022 Volume Weighted Average Price, in the amounts of 4,968,000 awarded to Sean Smith and 3,730,909 awarded to Alex Abrey.
The Options expire on 31 August 2027 and vest as follows:
1/3 upon grant
1/3 12 months from the date of grant
1/3 24 months from the date of grant
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.
Separately, the Board has agreed that it will extend the exercise date to 31 December 2023 for the 3,500,000 options (2,000,000 awarded to Sean Smith and 1,500,000 awarded to Alex Abrey) with a strike price of 6p which were granted to the Executives in April 2021 under the Company's LTIP and which were due to expire on 30 June 2023.
The extension has been agreed to due to the unusually long closed period that the Executives were placed in prior to the options' expiration date.
For further information contact:
Eden Research plc www.edenresearch.com Sean Smith Alex Abrey 01285 359 555 Cenkos Securities plc (Nominated advisor and broker) Giles Balleny / Max Gould (corporate finance) Michael Johnson (sales) 020 7397 8900 Hawthorn Advisors (Financial PR) Simon Woods eden@hawthornadvisors.com Felix Meston 1 Details of the person discharging managerial responsibilities / person closely associated --- ----------------------------------------------------------------------------------------------------------- a) Name Sean Smith --- ------------------------------------------------------------ --------------------------------------------- 2 Reason for the notification --- ----------------------------------------------------------------------------------------------------------- a) Position/status Chief Executive Officer --- ------------------------------------------------------------ --------------------------------------------- b) Initial notification /Amendment Initial Notification --- ------------------------------------------------------------ --------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ----------------------------------------------------------------------------------------------------------- a) Name Eden Research plc --- ------------------------------------------------------------ --------------------------------------------- b) LEI 213800ZWTYTVQQSM3J85 --- ------------------------------------------------------------ --------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------------------------------------------------------- a) Description of the financial instrument, type of instrument Options over ordinary shares of 1 pence each Identification code GB0001646941 --- ------------------------------------------------------------ --------------------------------------------- b) Nature of the transaction Grant of options --- ------------------------------------------------------------ --------------------------------------------- c) Price(s) and volume(s) Price(s) Volume(s) --------- ---------- 5.05p 4,968,000 --------- ---------- --- ------------------------------------------------------------ --------------------------------------------- d) Aggregated information - Aggregated volume - Price N/A --- ------------------------------------------------------------ --------------------------------------------- e) Date of the transaction 31 August 2023 --- ------------------------------------------------------------ --------------------------------------------- f) Place of the transaction Outside of trading venue --- ------------------------------------------------------------ --------------------------------------------- 1 Details of the person discharging managerial responsibilities / person closely associated --- ----------------------------------------------------------------------------------------------------------- a) Name Alex Abrey --- ------------------------------------------------------------ --------------------------------------------- 2 Reason for the notification --- ----------------------------------------------------------------------------------------------------------- a) Position/status Chief Financial Officer --- ------------------------------------------------------------ --------------------------------------------- b) Initial notification /Amendment Initial Notification --- ------------------------------------------------------------ --------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ----------------------------------------------------------------------------------------------------------- a) Name Eden Research plc --- ------------------------------------------------------------ --------------------------------------------- b) LEI 213800ZWTYTVQQSM3J85 --- ------------------------------------------------------------ --------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------------------------------------------------------- a) Description of the financial instrument, type of instrument Options over ordinary shares of 1 pence each Identification code GB0001646941 --- ------------------------------------------------------------ --------------------------------------------- b) Nature of the transaction Grant of options --- ------------------------------------------------------------ --------------------------------------------- c) Price(s) and volume(s) Price(s) Volume(s) --------- ---------- 5.05p 3,730,909 --------- ---------- --- ------------------------------------------------------------ --------------------------------------------- d) Aggregated information - Aggregated volume - Price N/A --- ------------------------------------------------------------ --------------------------------------------- e) Date of the transaction 31 August 2023 --- ------------------------------------------------------------ --------------------------------------------- f) Place of the transaction Outside of trading venue --- ------------------------------------------------------------ ---------------------------------------------, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHSDDFWFEDSEEA
(END) Dow Jones Newswires
August 31, 2023 13:25 ET (17:25 GMT)
1 Year Eden Research Chart |
1 Month Eden Research Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions